Yahoo Web Search

Search results

1. www.researchgate.net › profile › Thomas-Bartl-2Thomas BARTL | doctor-in-training | Doctor of Medicine | Medical...

   www.researchgate.net › profile › Thomas-Bartl-2

   Thomas BARTL, doctor-in-training | Cited by 131 | of Medical University of Vienna, Vienna (MedUni Vienna) | Read 49 publications | Contact Thomas BARTL

2. www.meduniwien.ac.at › web › enResearcher of the MedUni Vienna - Medical University of Vienna

   www.meduniwien.ac.at › web › en

   • Cached

   Thomas Bartl Grants A Novel Approach of Defining Therapeutic Targets in an Orphan Disease: Formalin-fixed paraffin-embedded Tumor Tissue and Ascites-derived Cell Pellets as a Promising Source for RNA-Profiling in Mucinous Ovarian Cancer (2021)

3. Images

   • 
   • 
   • 
   • 
   • 

   View all

4. www.meduniwien.ac.at › web › forschungResearcher of the MedUni Vienna

   www.meduniwien.ac.at › web › forschung

   • Cached

   Dr. med Thomas Bartl, MA Comprehensive Cancer Center, Department of Obstetrics and Gynecology (Division of General Gynecology and Gynecologic Oncology) Position: Consultant

5. www.facebook.com › public › Thomas-BartlThomas Bartl Profiles | Facebook

   www.facebook.com › public › Thomas-Bartl

   • Cached

   View the profiles of people named Thomas Bartl. Join Facebook to connect with Thomas Bartl and others you may know. Facebook gives people the power to...

6. at.linkedin.com › in › thomas-bartlThomas Bartl – Medical Specialist – Medizinische Universität Wien...

   at.linkedin.com › in › thomas-bartl

   Medical Specialist at the Department of Obstetrics and Gynecology at the Medical University of Vienna, currently undergoing subspecialty training in Gynecologic Oncology.

   • Works For: Medizinische Universität Wien
   • Occupation: Medical Specialist

   • Followers: 140
   • Location: Wien, Wien, Österreich

7. pubmed.ncbi.nlm.nih.gov › 33185042The systemic immune-inflammation index (SII) is an independent...

   pubmed.ncbi.nlm.nih.gov › 33185042

   The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer. J Gynecol Oncol. 2021 Jan;32 (1):e1. doi: 10.3802/jgo.2021.32.e1. Epub 2020 Oct 21.

8. pubmed.ncbi.nlm.nih.gov › 34827698Overweight as a Favorable Clinical Biomarker for Checkpoint ... -...

   pubmed.ncbi.nlm.nih.gov › 34827698

   Nov 16, 2021 · Abstract. Despite increasing clinical interest in adapting checkpoint inhibitor (CPI) therapies for patients with gynecologic malignancies, no accurate clinical biomarkers to predict therapy response and prognosis are currently available.